Ideación suicida en paciente a tratamiento con ombitasvir/ paritaprevir/ritonavir (Viekirax®), dasabuvir (Exviera®) y ribavirina (Rebetol®)
Guardat en:
| Publicat a: | Farmacia Hospitalaria |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Espanhol |
| Publicat: |
Sociedad Española de Farmacia Hospitalaria
2016
|
| Matèries: | |
| Accés en línia: | https://www.redalyc.org/articulo.oa?id=365964194011 https://www.redalyc.org/journal/3659/365964194011/ https://www.redalyc.org/journal/3659/365964194011/html/ https://www.redalyc.org/journal/3659/365964194011/365964194011.epub https://www.redalyc.org/journal/3659/365964194011/movil https://doi.org/10.7399/fh.2016.40.5.10553 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|